Published
In this brief webinar presented by Dr. Todd Bauer, we review the benefits and limitations of DNA and RNA sequencing technologies and the impact on the care of patients with advanced non-small cell lung cancer (NSCLC).
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
19:13
Utilizing 6.5F Set for Coronary Bifurcation Lesions Through d-TRA - Dr. Periklis Davlouros | EuroPCR
-
04:27
Living with HER2-mutated NSCLC
-
05:35
The latest NSCLC data presented at ELCC 2025
-
05:03
A Brief Review of DNA and RNA in Advanced NSCLC with Dr. Todd M. Bauer
-
04:05
Disparities in biomarker-targeted therapy for resected NSCLC
-
12:29
HER2 in NSCLC: Advances and Insights With Dr. Julia Kathleen Rotow
-
18:11
Part 1: Targeted Therapy for NSCLC: Toxicity Profile of ADCs
-
04:11
Managing oligoprogressive NSCLC during immune checkpoint inhibitor therapy
-
17:02
A Turning Point in HER2-Mutated NSCLC: What Clinicians Need to Know Now
-
18:13
180. Back to Basics - Metastatic NSCLC feat. KRAS and MET mutations
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
